{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T04:06:58Z","timestamp":1763611618650,"version":"3.45.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Research on CD9 expression has been extensive in B lymphoblastic leukemia, with fewer studies focusing on acute myeloid leukemia (AML). We investigated the usefulness of CD9 in differentiating normal from abnormal myeloid progenitors, as well as expression in normal cell types and in AML.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Flow cytometry was used to assess the level of CD9 expression on normal and leukemic myeloid blasts and other normal bone marrow populations. Geometric mean fluorescence intensity levels and expression patterns were compared among cell types and AML subtypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In normal subsets (n\u2005=\u200569), the level of CD9 expression was lowest in mature B cells, myeloid blasts, promyelocytes, and neutrophils, with intermediate expression in monocytes and highest in hematogones (stages 1 and 2). Committed myeloid progenitors (CMPs) had lower expression than hematopoietic stem cells (HSCs). CD9 typically has higher expression in AML (n\u2005=\u200558) compared to normal myeloid blasts and promyelocytes, and it is differentially expressed in AML, with the highest expression in PML::RARA AML.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Aberrant CD9 expression can be useful differentiating normal from abnormal myeloid progenitors, with the highest level of expression in AML with PML::RARA in our cohort. There was differential expression between HSCs and CMPs in the small numbers studied. Normal mature B cells can be used as an internal negative control in most cases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ajcp\/aqaf087","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T11:46:56Z","timestamp":1753444016000},"page":"694-703","source":"Crossref","is-referenced-by-count":0,"title":["CD9: Differential expression of normal bone marrow cellular components and leukemic myeloid blasts"],"prefix":"10.1093","volume":"164","author":[{"given":"Afreen","family":"Jasim","sequence":"first","affiliation":[{"name":"Department of Pathology, City of Hope Medical Center , Durate, CA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winston","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Pathology, City of Hope Medical Center , Durate, CA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiyan","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Computation and Quantitative Medicine, Beckman Research Institute, City of Hope Medical Center , Duarte CA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Quirk","sequence":"additional","affiliation":[{"name":"Department of Pathology, City of Hope Medical Center , Durate, CA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joo","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Pathology, City of Hope Medical Center , Durate, CA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Hwee","sequence":"additional","affiliation":[{"name":"Department of Pathology, City of Hope Medical Center , Durate, CA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Hughes","sequence":"additional","affiliation":[{"name":"Department of Pathology, City of Hope Medical Center , Durate, CA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parastou","family":"Tizro","sequence":"additional","affiliation":[{"name":"Department of Pathology, City of Hope Medical Center , Durate, CA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lori","family":"Soma","sequence":"additional","affiliation":[{"name":"Department of Pathology, City of Hope Medical Center , Durate, CA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,9,17]]},"reference":[{"key":"2025111922464039100_CIT0001","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1084\/jem.153.3.726","article-title":"P-24: a human leukemia-associated and lymphohemopoietic progenitor cell surface structure identified with monoclonal antibody","volume":"153","author":"Kersey","year":"1981","journal-title":"J Exp Med."},{"key":"2025111922464039100_CIT0002","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.3389\/fimmu.2018.02316","article-title":"CD9 tetraspanin: a new pathway for the regulation of inflammation","volume":"9","author":"Brosseau","year":"2018","journal-title":"Front Immunol."},{"key":"2025111922464039100_CIT0003","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1126\/science.287.5451.319","article-title":"Severely reduced female fertility in CD9-deficient mice","volume":"287","author":"Le Naour","year":"2000","journal-title":"Science."},{"key":"2025111922464039100_CIT0004","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrc3640","article-title":"Tetraspanin proteins promote multiple cancer stages","volume":"14","author":"Hemler","year":"2014","journal-title":"Nat Rev Cancer."},{"key":"2025111922464039100_CIT0005","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1182\/blood-2015-02-628560","article-title":"CD9, a key actor in the dissemination of lymphoblastic leukemia, modulating CXCR4-mediated migration via RAC1 signaling","volume":"126","author":"Arnaud","year":"2015","journal-title":"Blood."},{"key":"2025111922464039100_CIT0006","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s41375-023-02089-3","article-title":"Prognostic implications of CD9 in childhood acute lymphoblastic leukemia: insights from a nationwide multicenter study in China","volume":"38","author":"Leung","year":"2024","journal-title":"Leukemia."},{"key":"2025111922464039100_CIT0007","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bbrc.2009.02.123","article-title":"CD9 correlates with cancer stem cell potentials in human B-acute lymphoblastic leukemia cells","volume":"382","author":"Nishida","year":"2009","journal-title":"Biochem Biophys Res Commun."},{"key":"2025111922464039100_CIT0008","doi-asserted-by":"publisher","first-page":"781","DOI":"10.3233\/CBM-170422","article-title":"CD9 expression indicates a poor outcome in acute lymphoblastic leukemia","volume":"21","author":"Liang","year":"2018","journal-title":"Cancer Biomark."},{"key":"2025111922464039100_CIT0009","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1002\/cam4.2007","article-title":"CD9 in acute myeloid leukemia: prognostic role and usefulness to target leukemic stem cells","volume":"8","author":"Touzet","year":"2019","journal-title":"Cancer Med"},{"key":"2025111922464039100_CIT0010","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/00365513.2019.1700427","article-title":"Report of a new six-panel flow cytometry marker for early differential diagnosis of APL from HLA-DR negative non-APL leukemia","volume":"80","author":"Mosleh","year":"2020","journal-title":"Scand J Clin Lab Invest."},{"key":"2025111922464039100_CIT0011","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1365-2141.1994.tb04983.x","article-title":"Unique immunophenotype of acute promyelocytic leukaemia as defined by CD9 and CD68 antibodies","volume":"88","author":"Erber","year":"1994","journal-title":"Br J Haematol."},{"key":"2025111922464039100_CIT0012","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/0145-2126(91)90056-y","article-title":"CD9 antigen on acute non-lymphoid leukemia cells: preferential expression by promyelocytic (M3) subtype","volume":"15","author":"Ferrero","year":"1991","journal-title":"Leuk Res."},{"key":"2025111922464039100_CIT0013","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s12185-015-1923-9","article-title":"Stepwise discriminant function analysis for rapid identification of acute promyelocytic leukemia from acute myeloid leukemia with multiparameter flow cytometry","volume":"103","author":"Chen","year":"2016","journal-title":"Int J Hematol."},{"key":"2025111922464039100_CIT0014","doi-asserted-by":"publisher","first-page":"262","DOI":"10.5858\/arpa.2023-0460-OA","article-title":"Measurable residual disease analysis by flow cytometry and correlation with molecular measurable residual disease in acute promyelocytic leukemia: a real-world prospective study","volume":"149","author":"Wen","year":"2025","journal-title":"Arch Pathol Lab Med."},{"key":"2025111922464039100_CIT0015","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.leukres.2013.03.009","article-title":"NPM1-mutated acute myeloid leukemia of monocytic or myeloid origin exhibit distinct immunophenotypes","volume":"37","author":"Liu","year":"2013","journal-title":"Leuk Res."},{"key":"2025111922464039100_CIT0016","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1056\/NEJMoa031046","article-title":"Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia","volume":"350","author":"Bullinger","year":"2004","journal-title":"N Engl J Med."},{"key":"2025111922464039100_CIT0017","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1182\/blood.v112.11.3367.3367","article-title":"Regulation of CD9 expression by Runx1 in acute myeloid leukemia","volume":"112","author":"Racke","year":"2008","journal-title":"Blood."},{"key":"2025111922464039100_CIT0018","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1056\/NEJMoa040465","article-title":"Prognostically useful gene-expression profiles in acute myeloid leukemia","volume":"350","author":"Valk","year":"2004","journal-title":"N Engl J Med."},{"key":"2025111922464039100_CIT0019","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.4049\/jimmunol.166.5.3256","article-title":"Functional association of CD9 with the Fc gamma receptors in macrophages","volume":"166","author":"Kaji","year":"2001","journal-title":"J Immunol."},{"key":"2025111922464039100_CIT0020","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1189\/jlb.0812391","article-title":"Characterization of tetraspanins CD9, CD53, CD63, and CD81 in monocytes and macrophages in HIV-1 infection","volume":"93","author":"Tippett","year":"2013","journal-title":"J Leukoc Biol."},{"key":"2025111922464039100_CIT0021","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.3389\/fimmu.2018.03034","article-title":"CD9(+) regulatory B cells induce T cell apoptosis via IL-10 and are reduced in severe asthmatic patients","volume":"9","author":"Brosseau","year":"2018","journal-title":"Front Immunol."},{"key":"2025111922464039100_CIT0022","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bbrc.2012.12.102","article-title":"CD9 is a novel marker for plasma cell precursors in human germinal centers","volume":"431","author":"Yoon","year":"2013","journal-title":"Biochem Biophys Res Commun."},{"key":"2025111922464039100_CIT0023","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1182\/blood.v97.7.1982","article-title":"CD9 and megakaryocyte differentiation","volume":"97","author":"Clay","year":"2001","journal-title":"Blood."},{"key":"2025111922464039100_CIT0024","doi-asserted-by":"publisher","first-page":"e98561","DOI":"10.1172\/jci.insight.98561","article-title":"Universal monitoring of minimal residual disease in acute myeloid leukemia","volume":"3","author":"Coustan-Smith","year":"2018","journal-title":"JCI Insight"},{"key":"2025111922464039100_CIT0025","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/s41375-019-0593-7","article-title":"CD9 blockade suppresses disease progression of high-risk pediatric B-cell precursor acute lymphoblastic leukemia and enhances chemosensitivity","volume":"34","author":"Leung","year":"2020","journal-title":"Leukemia."},{"key":"2025111922464039100_CIT0026","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13287-021-02155-6","article-title":"CD9, a potential leukemia stem cell marker, regulates drug resistance and leukemia development in acute myeloid leukemia","volume":"12","author":"Liu","year":"2021","journal-title":"Stem Cell Res Ther."},{"key":"2025111922464039100_CIT0027","volume-title":"Haematolymphoid Tumours","author":"WHO Classification of Tumours Editorial Board","year":"2024","edition":"5"},{"volume-title":"The International Consensus Classification of Myeloid and Lymphoid Neoplasms","year":"2025","author":"Arber","key":"2025111922464039100_CIT0028"},{"key":"2025111922464039100_CIT0029","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/ajh.10176","article-title":"Assessment of CD24 expression on bone marrow neutrophilic granulocytes: CD24 is a marker for the myelocytic stage of development","volume":"71","author":"Elghetany","year":"2002","journal-title":"Am J Hematol."}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/164\/5\/694\/64302047\/aqaf087.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/164\/5\/694\/64302047\/aqaf087.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T03:46:47Z","timestamp":1763610407000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/164\/5\/694\/8256645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,17]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,9,17]]},"published-print":{"date-parts":[[2025,11,19]]}},"URL":"https:\/\/doi.org\/10.1093\/ajcp\/aqaf087","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"type":"print","value":"0002-9173"},{"type":"electronic","value":"1943-7722"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,9,17]]}}}